Companies / ADMA Biologics Inc

ADMA Biologics Inc

Nasdaq: ADMACIK 1368514RAMSEY, NJadmabiologics.com ↗

Financials · FY2025

Revenue$510.17M
Net income$146.93M
Total debt$196.59M
Cash$136.02M
Diluted EPS$0.60
Shares outstanding224.0M

Ownership

224.0M shares outstanding · as of Jul 31, 2026
2.6%Insiders
Ownership
Insiders2.64%5,921,727
10%+ / strategic13.05%29,226,175
Institutions94.10%210,760,455
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 10

View all →
Insider% of sharesShares
Elms SteveDirector
0.96%2,143,750
Grossman Adam SCEOPresident and CEO · Director
0.94%2,112,777
Grossman Jerrold BDirector
0.23%520,284
Kestenberg-Messina Kaitlin M.COO and SVP, Compliance
0.20%446,238
Kwon YoungDirector
0.12%263,020
Tade Brad L.CFO and Treasurer
0.10%232,940
Guiheen Lawrence P.Director
0.06%135,520
Finger Alison CecilyDirector
0.02%45,619
Salas Eduardo ReneDirector
<0.01%21,579
Kohler TerryCFO and Treasurer
——

Institutional holders 366

View all →
HolderValue% of shares
Vanguard Group Inc$380.39M9.31%
BlackRock, Inc.$321.04M17.12%
Invesco Ltd.$214.96M5.26%
Sachem Head Capital Management LP$207.48M5.08%
State Street Corporation$143.26M7.64%
Westfield Capital Management Company, L.P.$127.55M3.12%
Capital Research Global Investors$121.07M2.96%
Nuveen, LLC$108.10M2.65%
American Century Companies Inc$94.82M2.32%
Dimensional Fund Advisors LP$88.20M2.16%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 6, 2026Grossman Adam S
CEO
OtherCommon Stock$868.6K-56K
-2.56%
2,148,290
0.96% of shares
low
Feb 26, 2026Grossman Adam S
CEO
OtherCommon Stock$832.7K-55K
-2.43%
2,204,728
0.98% of shares
low
Mar 7, 2026Grossman Adam S
CEO
OtherCommon Stock$454.2K-30K
-1.37%
2,118,777
0.95% of shares
low
Feb 19, 2026Grossman Adam S
CEO
OtherCommon Stock$404.6K-25K
-1.09%
2,259,586
1.01% of shares
low
Feb 17, 2026Grossman Adam S
CEO
SellCommon Stock$241.2K-15K
-0.65%
2,290,379
1.02% of shares
medium
Mar 16, 2026Grossman Adam S
CEO
SellCommon Stock$227.4K-15K
-0.70%
2,118,777
0.95% of shares
medium
Apr 1, 2026Kestenberg-Messina Kaitlin M.
Executive
OtherCommon Stock$185.5K-20K
-4.36%
446,238
0.20% of shares
low
Mar 9, 2026Kestenberg-Messina Kaitlin M.
Executive
SellCommon Stock$157.8K-10K
-2.12%
466,600
0.21% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
State Street CorporationPassive13G—17,116,022—
Invesco Ltd.Passive13G/A———
Vanguard Capital ManagementPassive13G—12,110,153—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ADMA——000899104—